Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Ottawa

$29,000.00

Development of continuous multiphase microreactors for the production of fine chemicals

FY 2014-15

Summary
Many fine chemicals and pharmaceuticals are produced by solvent-intensive batch or semi-batch processes increasing costs and environmental impact. In comparison, continuous-flow microreactors offer a large surface-to-volume ratio and intimate contact between reactants, which leads to very high heat and mass transfer rates, permitting improved reaction control and selectivity at more severe operating conditions. This and their small volume enable safer handling of hazardous reactions and unstable intermediates. The overall goal of this research program is thus to develop continuous-flow microreactor technology sufficiently flexible that it can outperform batch/semi-batch reactors for a variety of single and multiphase reactions over production scales ranging from pharmaceutical clinical trial phases I (10-50 ml/min) to III (400-600 ml/min). Focus is primarily on molecules where synthesis is highly exothermic and/or limited by interphase mass transfer since these operating conditions are more difficult to optimize.A systematic and thorough experimental program will investigate: 1) Hydrodynamics and transport phenomena of gas-liquid flow without and with solid-supported catalyst in select and distinct reactor geometries. This will lead to criteria for choosing mixing structures based on desired contacting pattern and efficiency in dissipating energy, and to robust scaling rules. 2) Ring-closing metathesis of olefins and hydrogenation of nitriles, which are catalytic reactions of central importance in organic synthesis and take advantage of leading chemical expertise at the University of Ottawa. This will synergistically use and provide information towards part 1); forming stronger ties between chemists and engineers such that catalyst/reaction and reactor design are optimized concurrently. Deploying graduate students trained within a multidisciplinary science/engineering environment will help accelerate changes to manufacturing in the pharmaceutical industry, an important contributor to Canada's economy and well-being.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
261677-2013
Name nom
Macchi, Arturo
Department département
Chemical and Biological Engineering
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1801
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Reaction fundamentals and reactor design
Research subject fr
Principes des réactions et conception de réacteurs
Partie
2
Nb partie
5
Application title
Development of continuous multiphase microreactors for the production of fine chemicals
Keyword
NSERC
Application summary
Many fine chemicals and pharmaceuticals are produced by solvent-intensive batch or semi-batch processes increasing costs and environmental impact. In comparison, continuous-flow microreactors offer a large surface-to-volume ratio and intimate contact between reactants, which leads to very high heat and mass transfer rates, permitting improved reaction control and selectivity at more severe operating conditions. This and their small volume enable safer handling of hazardous reactions and unstable intermediates. The overall goal of this research program is thus to develop continuous-flow microreactor technology sufficiently flexible that it can outperform batch/semi-batch reactors for a variety of single and multiphase reactions over production scales ranging from pharmaceutical clinical trial phases I (10-50 ml/min) to III (400-600 ml/min). Focus is primarily on molecules where synthesis is highly exothermic and/or limited by interphase mass transfer since these operating conditions are more difficult to optimize.A systematic and thorough experimental program will investigate: 1) Hydrodynamics and transport phenomena of gas-liquid flow without and with solid-supported catalyst in select and distinct reactor geometries. This will lead to criteria for choosing mixing structures based on desired contacting pattern and efficiency in dissipating energy, and to robust scaling rules. 2) Ring-closing metathesis of olefins and hydrogenation of nitriles, which are catalytic reactions of central importance in organic synthesis and take advantage of leading chemical expertise at the University of Ottawa. This will synergistically use and provide information towards part 1); forming stronger ties between chemists and engineers such that catalyst/reaction and reactor design are optimized concurrently. Deploying graduate students trained within a multidisciplinary science/engineering environment will help accelerate changes to manufacturing in the pharmaceutical industry, an important contributor to Canada's economy and well-being.